When in doubt should we cut it out? The role of surgery in non-small cell lung cancer

Holty, J.-E. C.; Gould, M. K.
July 2006
Thorax;Jul2006, Vol. 61 Issue 7, p554
Academic Journal
The author mentions several studies on the use of surgical resection and poses the question if surgery indeed is effective in patients with resectable non-small-cell lung cancer (NSCLC). The article analyzes the benefits of surgical resection of lung cancer based on post-operative quality of life and randomized controlled trials with scant evidence or studies.


Related Articles

  • Surgery.  // Current Medical Literature: Lung Cancer;2013, Vol. 6 Issue 3, p75 

    The article discusses several studies related to lung cancer published in various medical journals in 2012. A study by D. De Ruysscher et al showed an improvement over the median survival of the typical patient with stage IV non-small-cell lung carcinoma (NSCLC). A. Barua et al evaluated the use...

  • Management of an incidentally discovered pulmonary nodule. Beigelman-Aubry, Catherine; Hill, Catherine; Grenier, Philippe A. // European Radiology;Feb2007, Vol. 17 Issue 2, p449 

    The incidental finding of a pulmonary nodule on computed tomography (CT) is becoming an increasingly frequent event. The discovery of such a nodule should evoke the possibility of a small bronchogenic carcinoma, for which excision is indicated without delay. However, invasive diagnostic...

  • Impact of symptom burden in post-surgical non-small cell lung cancer survivors. Lowery, Amy E.; Krebs, Paul; Coups, Elliot J.; Feinstein, Marc B.; Burkhalter, Jack E.; Park, Bernard J.; Ostroff, Jamie S. // Supportive Care in Cancer;Jan2014, Vol. 22 Issue 1, p173 

    Purpose: Pain, fatigue, dyspnea, and distress are commonly reported cancer-related symptoms, but few studies have examined the effects of multiple concurrent symptoms in longer-term cancer survivors. We examined the impact of varying degrees of symptom burden on health-related quality of life...

  • Lung cancer symptoms and pulse oximetry in the prognostic assessment of patients with lung cancer. Martins, Sandro J.; Ho, Nelson; Cavamura, Sueli O.; Harada, Cecilia M.; Yamamoto, Crystina A.; Takagaki, Teresa Y. // BMC Cancer;2005, Vol. 5, p72 

    Background: Medical oncologists continue to use performance status as a proxy for quality of life (QOL) measures, as completion of QOL instruments is perceived as time consuming, may measure aspects of QOL not affected by cancer therapy, and interpretation may be unclear. The pulse oximeter is...

  • The voice of postsurgical lung cancer patients regarding supportive care needs. Hoffman, Amy J.; Brintnall, Ruth Ann; von Eye, Alexander; Cooper, Julie; Brown, Jean K. // Lung Cancer: Targets & Therapy;2014, Vol. 5, p21 

    Objective: Individuals with lung cancer present with multiple comorbid conditions and complex treatment plans. They are frequently vulnerable during critical transitions in the cancer survivorship trajectory. Limited research exists on the postsurgical non-small-cell lung cancer (NSCLC)...

  • Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and design. Sommer, Maja S.; Trier, Karen; Vibe-Petersen, Jette; Missel, Malene; Christensen, Merete; Larsen, Klaus R.; Langer, Seppo W.; Hendriksen, Carsten; Clementsen, Paul; Pedersen, Jesper H.; Langberg, Henning // BMC Cancer;2014, Vol. 14 Issue 1, p1380 

    Background The purpose of the PROLUCA study is to investigate the efficacy of preoperative and early postoperative rehabilitation in a non-hospital setting in patients with operable lung cancer with special focus on exercise. Methods Using a 2x2 factorial design with continuous effect endpoint...

  • Pleuropneumonectomy for diffuse pleural metastasis in primary lung cancer. Wen-Bo Jin; Chao-Yang Liang; Yang-Hong Peng; Nai-Kang Zhou // Journal of Cancer Research & Therapeutics;2013 Supplement 2, Vol. 9, pS92 

    Objective: The purpose of this study is to analyze a single institution experience with pleuropneumonectomy for pleural metastasis and malignant pleural effusion in primary lung cancer. Materials and Methods: From August 1978 to August 2011, 66 consecutive patients with lung cancer underwent...

  • High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer. LUNQING WANG; ZHOU WANG; XIANGYAN LIU; FANYING LIU // Oncology Letters;2014, Vol. 7 Issue 6, p1871 

    Brain-specific metastasis is one of the primary causes of recurrence following complete resection of non-small cell lung cancer (NSCLC) and the underlying mechanism remains unclear. The present study was designed to investigate the correlation between C-X-C chemokine receptor type 4 (CXCR4)...

  • Size of Stage IIIA Primary Lung Cancers and Survival: A Surveillance, Epidemiology and End Results Database Analysis. MAXIMUS, STEVEN; NGUYEN, DANH V.; YI MU; CALHOUN, ROYCE F.; COOKE, DAVID T. // American Surgeon;Nov2012, Vol. 78 Issue 11, p1232 

    Size of early-stage lung cancer is important in the prognosis of patients. We examined the large population-based Surveillance, Epidemiology and End Results database to determine if tumor size was an independent risk factor of survival in patients undergoing lobectomy for N2 positive Stage IIIA...


Read the Article


Sign out of this library

Other Topics